COVID-19 rapid guideline: managing COVID-19

Search strategies Reducing the risk of venous thromboembolism in over 16s with COVID-19 (PDF 261 KB)

Review questions Reducing the risk of venous thromboembolism in over 16s with COVID-19 RQ1 (PDF 839 KB)

Case study - Study characteristics of studies informing recommendation for remdesivir (PDF 206 KB)

Supporting documentation Peer review thematic summary -  Colchicine (PDF 135 KB)

Supporting documentation Peer review thematic summary -  remdesivir (PDF 139 KB)

Supporting documentation Peer review thematic summary -  azithromycin (PDF 136 KB)

Supporting documentation Peer review thematic summary -  doxycycline (PDF 123 KB)

Supporting documentation Peer review thematic summary -  heparins (PDF 168 KB)

Supporting documentation Peer review thematic summary - respiratory support (PDF 205 KB)

Supporting documentation Peer review thematic summary - casirivimad & imdevimab (hospitalised) (PDF 260 KB)

Supporting documentation Peer review thematic summary - budesonide (inhaled) (PDF 134 KB)

Supporting documentation Peer review thematic summary -  ivermectin (PDF 149 KB)

Supporting documentation Peer review thematic summary -  CAPA (PDF 171 KB)

Supporting documentation Peer review thematic summary - neutralising monoclonal antibodies for people not in hospital (PDF 165 KB)

Supporting documentation Peer review thematic summary -  Antivirals (PDF 202 KB)

Supporting documentation Peer review thematic summary - prone positioning and non-invasive respiratory support (PDF 182 KB)

Supporting documentation peer review thematic summary - nirmatrelvir and ritonavir (Paxlovid) (PDF 109 KB)

Supporting documentation Peer review thematic summary - baricitinib (PDF 114 KB)

Supporting documentation Peer review thematic summary - ivermectin update (PDF 113 KB)

Supporting documentation Peer review thematic summary - Remdesivir update (PDF 124 KB)